American Well Corporation (AMWL)
$
7.1
-0.15 (-2.11%)
Key metrics
Financial statements
Free cash flow per share
-5.2085
Market cap
114.7 Million
Price to sales ratio
0.4251
Debt to equity
0.0226
Current ratio
3.2947
Income quality
0.6070
Average inventory
2.4 Million
ROE
-0.4089
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
American Well Corporation operates as a telehealth software company that facilitates the digital delivery of healthcare services. The financial data pertains to the fiscal year 2024 with the company reporting total costs and expenses of $471,898,000.00 reflecting its overall spending. Additionally, the company reported selling, general, and administrative expenses of $197,446,000.00 indicating its operational overhead costs. It also reported depreciation and amortization expenses of $32,973,000.00 which reflects the wear and tear of its assets. Furthermore, the company showcased its pre-tax profitability by reporting an income before tax of -$206,777,000.00. The company’s product offerings include urgent care, scheduled visits, acute behavioral health, telestroke, pediatrics, and services tailored for retail health, school health, and home settings. Its application caters to various healthcare needs such as pediatrics, therapy, menopause nutrition, end-stage renal disease and dialysis, dermatology care, behavioral health therapy, and musculoskeletal care. American Well also supplies telemedicine equipment, which includes telemedicine carts, peripherals, Tyto care, TV kits, tablets, and kiosks. Founded in 2006, the company is headquartered in Boston, Massachusetts. In the stock market, the company presents an appealing investment opportunity, with the stock being affordable at $8.08 making it suitable for budget-conscious investors. Under the financial umbrella, it has a low average trading volume of 52,011.00 indicating lower market activity, which may attract a certain type of investment strategy. With a market capitalization of $114,679,910.00 the company is classified as a small-cap player, positioning it in a niche category that often holds potential for growth. It is a key player in the Medical - Healthcare Information Services industry, contributing significantly to the overall market landscape and driving forward innovation and growth within the field. As part of the Healthcare sector, American Well Corporation not only represents a unique investment but also plays a critical role in advancing healthcare accessibility through its telehealth solutions.
Investing in American Well Corporation (AMWL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict American Well Corporation stock to fluctuate between $6.10 (low) and $12.95 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-08-20, American Well Corporation's market cap is $114,679,910, based on 16,152,100 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, American Well Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy American Well Corporation (AMWL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AMWL. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
American Well Corporation's last stock split was 1:20 on 2024-07-11.
Revenue: $254,364,000 | EPS: -$13.88 | Growth: -70.78%.
Visit https://amwell.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $233.60 (2021-08-06) | All-time low: $5 (2024-07-01).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to higher-margin software revenue is promising, but guidance was revised downward due to contract uncertainties and program exclusions. Cost reductions have improved EBITDA and cash flow outlook, but excessive cuts risk undermining R&D, marketing, and future growth potential.
globenewswire.com
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees' employment with Amwell.
fool.com
American Well (AMWL 21.02%), a major telehealth solutions provider, reported second-quarter 2025 results on August 5, 2025. The standout detail: GAAP revenue of $70.9 million in Q2 2025 outpaced analyst expectations by more than $7.4 million, alongside a record gross margin of 56.1% in Q2 2025.
zacks.com
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
seekingalpha.com
American Well Corporation (NYSE:AMWL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue Dooley - Head of Investor Relations Conference Call Participants Eric R.
zacks.com
American Well Corporation (AMWL) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.84. This compares to a loss of $3.36 per share a year ago.
globenewswire.com
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension of its next-generation Digital First contract to power the digital transformation of the Military Health System (MHS), which serves approximately 9.6 million beneficiaries. Under the contract extension, Amwell will continue to provide its comprehensive technology-enabled care platform to power virtual care delivered by MHS providers.
zacks.com
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
zacks.com
HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.
zacks.com
American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
See all news